Selenium in renal cell carcinoma showed context dependent redox effects, lowering reactive oxygen species in baseline ...

Encellin, a biotechnology company pioneering Encapsulated Cell Replacement Therapy (ENCRT), today announced interim clinical results from its ongoing Phase 1 investigational trial (NCT06408311) in ...

Antioxidants have long been regarded as key players in protecting cells and maintaining health, but a research team led by ...

Three local high school students were named among the top 300 scholars in the Regeneron Science Talent Search 2026, the ...

Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...

Akadeum Life Sciences, the leader in buoyant microbubble cell separation, today announced that its Chief Executive Officer ...

A combination of silybin and carvedilol for treating liver fibrosis is more effective than either drug alone. | Drug ...

Pancreatic ductal adenocarcinoma (PDAC) is both the most common and the deadliest type of pancreatic cancer. Most treatment ...

The global cell cryopreservation market size was valued at US$ 14.9 Bn in 2024 and is projected to reach US$ 104.8 Bn by 2035 ...

Gujarat is leading India's solar cell manufacturing with significant investments and capacity expansions, positioning itself ...

Scientists have found that combining silybin with carvedilol works far better against liver fibrosis than either drug alone.